Lisa M Hess

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 25

Top Topics

Metastatic Colorectal Cancer

Small Cell Lung Cancer

Top Venues

Journal of medical economics

Advances in hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Lisa M Hess, Yimei Han, Yajun Emily Zhu, Naleen Raj Bhandari, Anthony Sireci
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States. BMC cancer 23 (1) (2023)
Naleen Raj Bhandari, Lisa M Hess, Rohan C Parikh, Anthony N Sireci, Peter M Krein, James A Kaye
Biomarker testing in patients diagnosed with advanced/metastatic medullary thyroid cancer in the United States. Personalized medicine (2023)
Lisa M Hess, Yimei Han, Yajun Emily Zhu, Naleen Raj Bhandari, Anthony Sireci
Correction: Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States. BMC cancer 23 (1) (2023)
Debora S Bruno, Lisa M Hess, Xiaohong Li, Eric Wen Su, Monaliben Patel
Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States. JCO precision oncology 6 (2022)
Lisa M Hess, Diane Michael, Peter M Krein, Tyler Marquart, Anthony N Sireci
Costs of biomarker testing among patients with metastatic lung or thyroid cancer in the USA: a real-world commercial claims database study. Journal of medical economics (2022)
Lisa M Hess, Yongmei Chen, Paolo B Abada, Heiko Konig, Richard A Walgren
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study. Advances in hematology 2022 (2022)
Lisa M Hess, Yongmei Chen, Paolo B Abada, Heiko Konig, Richard A Walgren
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records Study. Advances in hematology 2022 (2022)
Alan Brnabic, Lisa M Hess
Systematic literature review of machine learning methods used in the analysis of real-world data for patient-provider decision making. BMC medical informatics and decision making 21 (1) (2021)
Lisa M Hess, Xiaohong Li, Yixun Wu, Robert J Goodloe, Zhanglin Lin Cui
Defining treatment regimens and lines of therapy using real-world data in oncology. Future oncology (London, England) 17 (15) (2021)
Lisa M Hess, Yajun Emily Zhu, Yun Fang, Astra M Liepa
Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer. Journal of medical economics 24 (1) (2021)
Naleen Raj Bhandari, Lisa M Hess, Yimei Han, Yajun E Zhu, Anthony N Sireci
Efficacy of immune checkpoint inhibitor therapy in patients with RET fusion-positive non-small-cell lung cancer. Immunotherapy 13 (11) (2021)
Lisa M Hess, Yimei Han, Yajun Emily Zhu, Naleen Raj Bhandari, Anthony Sireci
Characteristics and outcomes of patients with RET-fusion positive non-small lung cancer in real-world practice in the United States. BMC cancer 21 (1) (2021)
Michael Grabner, Cliff Molife, Liya Wang, Katherine B Winfree, Zhanglin Lin Cui, Gebra Cuyun Carter, Lisa M Hess
Data Integration to Improve Real-world Health Outcomes Research for Non-Small Cell Lung Cancer in the United States: Descriptive and Qualitative Exploration. JMIR cancer 7 (2) (2021)
Lisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, Cliff Molife, Ana B Oton
Treatment sequencing for the care of patients with advanced or metastatic non-small cell lung cancer in the United States. Current medical research and opinion 37 (3) (2021)
Lisa M Hess, David Smith, Zhanglin L Cui, Leslie Montejano, Astra M Liepa, William Schelman, Lee Bowman
The relationship between Eastern Cooperative Oncology Group performance status and healthcare resource utilization among patients with advanced or metastatic colorectal, lung or gastric cancer. Journal of drug assessment 10 (1) (2020)
Jasmina Ivanova, Lisa M Hess, Viviana Garcia-Horton, Sophia Graham, Xinyue Liu, Yajun Zhu, Steven Nicol
Patient and Oncologist Preferences for the Treatment of Adults with Advanced Soft Tissue Sarcoma: A Discrete Choice Experiment. The patient 12 (4) (2020)
Eric Nadler, Kathleen Marie Aguilar, Chuck Wentworth, Marley Boyd, E Susan Amirian, Scott Barker, Pearl French, Thomas Wilson, Lisa M Hess
Treatment Patterns and Healthcare Resource Utilization among Patients with Advanced or Metastatic Soft Tissue Sarcoma in US Community Practices. Sarcoma 2020 (2020)
Lisa M Hess, Michael Grabner, Liya Wang, Astra M Liepa, Xiaohong Ivy Li, Zhanglin Lin Cui, Lee Bowman, William R Schelman
Reliability of Conclusions from Early Analyses of Real-World Data for Newly Approved Drugs in Advanced Gastric Cancer in the United States. Pragmatic and observational research 11 (2020)
Deirdre Mladsi, Lisa M Hess, Christine L Barnett, Annete Njue, Yu-Jing Huang, Zhanglin Lin Cui, Lee Bowman
Value of clinical trial narrative data to estimate the costs of adverse event management: a feasibility study. Journal of medical economics 23 (3) (2019)
Lisa M Hess, Zhanglin Lin Cui, Daniel S Mytelka, Yimei Han, Robert Goodloe, William Schelman
Treatment patterns and survival outcomes for patients receiving second-line treatment for metastatic colorectal cancer in the USA. International journal of colorectal disease 34 (4) (2019)
Afsaneh Barzi, Lisa M Hess, Yajun E Zhu, Astra M Liepa, Tomoko Sugihara, Julie Beyrer, Joseph Chao
Real-World Outcomes and Factors Associated With the Second-Line Treatment of Patients With Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma. Cancer control : journal of the Moffitt Cancer Center 26 (1) (2019)
Lisa M Hess, Zhanglin Lin Cui, Xiaohong Ivy Li, Ana B Oton, Scott Shortenhaus, Ian A Watson
Drug wastage and costs to the healthcare system in the care of patients with non-small cell lung cancer in the United States. Journal of medical economics 21 (8) (2018)
Santiago Zuluaga-Sanchez, Lisa M Hess, Sorrel E Wolowacz, Yulia D'yachkova, Emma Hawe, Adrian D Vickers, James A Kaye, David Bertwistle
Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States. Sarcoma 2018 (2018)
Rohan C Parikh, Maria Lorenzo, Lisa M Hess, Sean D Candrilli, Steven Nicol, James A Kaye
Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas. Clinical sarcoma research 8 (2018)
Lisa M Hess, David M Kern, Gebra Cuyun Carter, Katherine B Winfree, Liya Wang, Angelina Sontag, Ana B Oton
Real-World Treatment Sequences and Outcomes Among Patients With Non-Small Cell Lung Cancer (RESOUNDS) in the United States: Study Protocol. JMIR research protocols 6 (10) (2017)